EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The use of mesenchymal stromal cell secretome to enhance guided bone regeneration in comparison with leukocyte and platelet‐rich fibrin

Siddharth Shanbhag iD, Niyaz Al-Sharabi iD, Carina Kampleitner, Samih Mohamed-Ahmed, Einar K Kristoffersen, Stefan Tangl, Kamal Mustafa, Reinhard Gruber iD, Mariano Sanz

Clinical Oral Implants Research · 2024-02 · 35 (2) · 141-154

DOI: 10.1111/clr.14205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Implants Research, online erschienen am 14.11.2023. Verfasst von Siddharth Shanbhag und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Mesenchymal Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Osteology Foundation, Switzerland, Helse Vest Research Funding, Norway, Trond Mohn Foundation, Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Secretomes of mesenchymal stromal cells (MSC) represent a novel strategy for growth‐factor delivery for tissue regeneration. The objective of this study was to compare the efficacy of adjunctive use of conditioned media of bone‐marrow MSC (MSC‐CM) with collagen barrier membranes vs. adjunctive use of conditioned media of leukocyte‐ and platelet‐rich fibrin (PRF‐CM), a current growth‐factor therapy, for guided bone regeneration (GBR).

Methods

MSC‐CM and PRF‐CM prepared from healthy human donors were subjected to proteomic analysis using mass spectrometry and multiplex immunoassay. Collagen membranes functionalized with MSC‐CM or PRF‐CM were applied on critical‐size rat calvaria defects and new bone formation was assessed via three‐dimensional (3D) micro‐CT analysis of total defect volume (2 and 4 weeks) and 2D histomorphometric analysis of central defect regions (4 weeks).

Results

While both MSC‐CM and PRF‐CM revealed several bone‐related proteins, differentially expressed proteins, especially extracellular matrix components, were increased in MSC‐CM. In rat calvaria defects, micro‐CT revealed greater total bone coverage in the MSC‐CM group after 2 and 4 weeks. Histologically, both groups showed a combination of regular new bone and ‘hybrid’ new bone, which was formed within the membrane compartment and characterized by incorporation of mineralized collagen fibers. Histomorphometry in central defect sections revealed greater hybrid bone area in the MSC‐CM group, while the total new bone area was similar between groups.

Conclusion

Based on the in vitro and in vivo investigations herein, functionalization of membranes with MSC‐CM represents a promising strategy to enhance GBR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich FibrinMesenchymal Stem CellsRatsHumansAnimalsCulture Media, ConditionedProteomicsSecretomeBone RegenerationIntercellular Signaling Peptides and ProteinsCollagenSkullLeukocytes

Stichwörter der Autor:innen

bone tissue engineeringconditioned mediaguided bone regenerationmesenchymal stromal cellsregenerative medicine

Substanzen

Culture Media, ConditionedIntercellular Signaling Peptides and ProteinsCollagen

Autor:innen und Institutionen

  • Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
  • Center for Translational Oral Research (TOR), Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Karl Donath Laboratory for Hard Tissue and Biomaterial Research, Division of Oral Surgery, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.
  • Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, The Research Center in Cooperation with AUVA, Vienna, Austria.
  • Austrian Cluster for Tissue Regeneration, Vienna, Austria.
  • Department of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Siddharth Shanbhag, Niyaz Al-Sharabi, Reinhard Gruber

Förderung

  • Osteology Foundation, Switzerland
  • Helse Vest Research Funding, Norway
  • Trond Mohn Foundation, Norway
  • Osteology Foundation

Zitieren

APA

Shanbhag, S., Al-Sharabi, N., Kampleitner, C., Mohamed-Ahmed, S., Kristoffersen, E. K., Tangl, S., Mustafa, K., Gruber, R., & Sanz, M. (2024). The use of mesenchymal stromal cell secretome to enhance guided bone regeneration in comparison with leukocyte and platelet‐rich fibrin. Clinical Oral Implants Research, 35(2), 141-154. https://doi.org/10.1111/clr.14205

Vancouver

Shanbhag S, Al-Sharabi N, Kampleitner C, Mohamed-Ahmed S, Kristoffersen EK, Tangl S, et al. The use of mesenchymal stromal cell secretome to enhance guided bone regeneration in comparison with leukocyte and platelet‐rich fibrin. Clinical Oral Implants Research. 2024;35(2):141-154. doi:10.1111/clr.14205

BibTeX
@article{Shanbhag2024,
  author = {Shanbhag, Siddharth and Al-Sharabi, Niyaz and Kampleitner, Carina and Mohamed-Ahmed, Samih and Kristoffersen, Einar K and Tangl, Stefan and Mustafa, Kamal and Gruber, Reinhard and Sanz, Mariano},
  title = {The use of mesenchymal stromal cell secretome to enhance guided bone regeneration in comparison with leukocyte and platelet‐rich fibrin},
  journal = {Clinical Oral Implants Research},
  year = {2024},
  volume = {35},
  number = {2},
  pages = {141--154},
  doi = {10.1111/clr.14205}
}
Kostenlos starten →